Galcanezumab

What it is used for

EMGALITY ® is a calcitonin-gene related peptide antagonist indicated in adults for the: preventive treatment of migraine. treatment of episodic cluster headache. Migraine EMGALITY is indicated for the preventive treatment of migraine in adults. Episodic Cluster Headache EMGALITY is indicated for the treatment of episodic cluster headache in adults.

Side effects, and when to stop

The following clinically significant adverse reactions are described elsewhere in the labeling:

• Hypersensitivity Reactions
• Constipation with Serious Complications
• Hypertension
• Raynaud's Phenomenon

Who should not take it

EMGALITY is contraindicated in patients with serious hypersensitivity to galcanezumab-gnlm or to any of the excipients.

Storing it

• Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect EMGALITY from light until use.
• Do not freeze.
• Do not shake.
• EMGALITY may be stored out of refrigeration in the original carton at temperatures up to 30°C (86°F) for up to 7 days. Once stored out of refrigeration, do not place back in the refrigerator.
• If these conditions are exceeded, EMGALITY must be discarded.
• Discard the EMGALITY single-dose prefilled pen or syringe after use in a puncture-resistant container.